The Follow-up of Mesh/Native Tissue Complications Study(Part I)

August 3, 2018 updated by: Peking Union Medical College Hospital

A Multi-center Study: The Follow-up of Complications for Women Having Pelvic Reconstruction Surgery With Mesh/Native Tissue(Part I)

This study aims to investigate the incidence and distribution of complications after different pelvic reconstruction surgeries using mesh/native tissue in multi-centers using the IUGA/ICS complication classification system(the Category-Time-Site(CTS) coding).

Study Overview

Status

Recruiting

Conditions

Detailed Description

Patients who undergo different pelvic floor reconstructive surgeries for the cure of pelvic organ prolapse(POP)and/or stress urinary incontinence(SUI) between June 2018 and June 2023 from 27 tertiary hospitals are prospectively collected.Our study aims to follow-up and report the incidences of postoperative complications according to the International Urogynecological Association-International Continence Society(IUGA-ICS) Complication Classification Coding(Category-Time-Site coding system).The aimed pelvic floor reconstructive surgeries involve anterior,apical, posterior or total pelvic reconstruction with trans-vaginal mesh,open/laparoscopic sacrocolpopexy(Y-tape/self-cut synthesized mesh),repair using native tissue(sacrospinous ligament fixation, high uterosacral ligament suspension,ischial spinous fascia fixation, the Lefort operation and so on)and as well as anti-urinary incontinence surgeries(tension-free vaginal tape).

Our follow-up process start after patients have completed the operation,thus our study do not affect patients' choice of surgical method.

Study Type

Observational

Enrollment (Anticipated)

13120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beiing
      • Beijing, Beiing, China, 100730
        • Recruiting
        • Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 76 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Patients who undergo different pelvic floor reconstructive surgeries for the cure of pelvic organ prolapse (POP) and/or stress urinary incontinence (SUI) between June 2018 and June 2023 from 27 tertiary hospitals are prospectively collected.

Description

Inclusion Criteria:

- 1. Patients who undergo pelvic floor reconstructive surgeries for pelvic organ prolapse and/or stress urinary incontinence. The aimed pelvic floor reconstructive surgeries involve anterior, apical, posterior or total pelvic reconstruction with trans-vaginal mesh, open/laparoscopic sacrocolpopexy (Y-shape tape/self-cut synthesized mesh), repair using native tissue(sacrospinous ligament fixation, high uterosacral ligament suspension, ischial spinous fascia fixation, the Lefort operation and so on) and as well as anti-urinary incontinence surgeries(tension-free vaginal tape). The indications are respectively as follows:

  1. Total pelvic reconstruction with trans-vaginal mesh Indications: 1) Patients experienced recurrence of prolapse in the same compartment that has a history of pelvic floor repair surgery; 2) The choice for elder patients who will accept primary surgery for advanced POP (staging III or IV).
  2. Open/Laparoscopic sacrocolpopexy (Y-shape tape/self-cut synthesized mesh) Indications: 1) Presenting with at least 3 prolapse of the uterus, with or without concomitant cystocele and rectocele; 2) Symptomatic stage 2 or greater prolapse of the vaginal vault or apical recurrence.
  3. Repair using native tissue(sacrospinous ligament fixation, high uterosacral ligament suspension, ischial spinous fascia fixation, Lefort) Indications:1)Presenting symptomatic stage 2 or greater prolapse of the uterus, with or without concomitant cystocele and rectocele. The procedure(sacrospinous ligament fixation, high uterosacral ligament suspension, ischial spinous fascia fixation) usually is performed after hysterectomy or when the uterus is preserved. 2)If postmenopausal women present with advanced uterus or vaginal apex prolapse, and have no desire of sexual life, the Lefort operation would be performed.
  4. Anti-urinary incontinence surgeries: tension-free vaginal tape. Indications: Stress urinary incontinence(SUI) patients who have 1)hyperactivity of urethra, or 2)internal urethral sphincter disorder; Or 3)mainly presenting SUI symptoms in patients with mixed urinary incontinence.

2. The failure or recurrence of prolapse the same compartment that has been underwent repair using native tissue.

Exclusion Criteria:

  • (1) the recurrence occurred on the same pelvic compartment with a prior history of prolapse repair surgery using mesh, an implant or a graft; (2) a prior history of anti-incontinence surgery using tape; however, patients who are inferred to accept procedures for POP this time are not included; (3) acute/chronic pelvic inflammation, genital tract infections;(4) any severe medical diseases that precluded the operations.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Laparoscopic sacrocolpopexy(LSC)
Patients who prefer to accept laparoscopic sacrocolpopexy after hysterectomy. For patients who has desire of uterine-preservation,laparoscopic sacrocervicopexy or sacrohysteropexy is carried.
Reconstruction with transvaginal mesh(TVM)
Patients who undertake pelvic reconstruction with tran-vaginal mesh(commercial mesh kits or self-cut synthesized mesh).
Reconstruction with native tissue(NT)
Patients who prefer to accept reconstruction with native tissue,mainly including high uterosacral ligament suspension, sacrospinous ligament fixation,ischial spinous fascia fixation,the Lefort operation.
Tension-free vaginal tape surgery(TVT)
Patients who undertake anti-incontinence surgeries(tension-free vaginal tape procedure).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The frequency and incidence rate of different complications
Time Frame: at 6-week postoperatively
Postoperative follow-up and record the occurrence of complications according to the International Urogynecological Association-International Continence Society(IUGA-ICS)Complication Classification Coding(Category-Time-Site coding system).
at 6-week postoperatively
The frequency and incidence rate of different complications
Time Frame: at 3-month postoperatively
Postoperative follow-up and record the occurrence of complications according to the International Urogynecological Association-International Continence Society(IUGA-ICS)Complication Classification Coding(Category-Time-Site coding system).
at 3-month postoperatively
The frequency and incidence rate of different complications
Time Frame: at 1-year postoperatively
Postoperative follow-up and record the occurrence of complications according to the International Urogynecological Association-International Continence Society(IUGA-ICS)Complication Classification Coding(Category-Time-Site coding system).
at 1-year postoperatively
The frequency and incidence rate of different complications
Time Frame: at 2-year postoperatively
Postoperative follow-up and record the occurrence of complications according to the International Urogynecological Association-International Continence Society(IUGA-ICS)Complication Classification Coding(Category-Time-Site coding system).
at 2-year postoperatively
The frequency and incidence rate of different complications
Time Frame: up to 3-year postoperatively
Postoperative follow-up and record the occurrence of complications according to the International Urogynecological Association-International Continence Society(IUGA-ICS)Complication Classification Coding(Category-Time-Site coding system).
up to 3-year postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anatomical cure rates in treated compartment of different pelvic reconstructive surgeries
Time Frame: 6 weeks, 3 months and each year, up to 3-year postoperatively
The percentage of patients who reach the anatomical success criteria at each time point(6 weeks, 3 months and each year, up to 3-year postoperatively)
6 weeks, 3 months and each year, up to 3-year postoperatively
Change from Preoperative scores of POP-Q(Pelvic organ prolapse quantitation) at each follow-up
Time Frame: Preoperatively; At 6weeks, 3 months, 1 year and assessed up to 3 year postoperatively.
POP-Q is used for evaluation the severity(staging) of prolapse by pelvic examination preoperatively and postoperatively. The score is reported in cm. The changes from baseline scores at 6 weeks, 3 months, 1 year and up to 3 years postoperatively are respectively compared.
Preoperatively; At 6weeks, 3 months, 1 year and assessed up to 3 year postoperatively.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2018

Primary Completion (Anticipated)

June 1, 2023

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

July 6, 2018

First Submitted That Met QC Criteria

August 3, 2018

First Posted (Actual)

August 8, 2018

Study Record Updates

Last Update Posted (Actual)

August 8, 2018

Last Update Submitted That Met QC Criteria

August 3, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pelvic Floor

Subscribe